About me
Ebony Dashiell-Aje, PhD is the Executive Director & Head of Patient Centered Outcomes Science in Clinical Development, at BioMarin. Dr. Dashiell-Aje is a leading expert in clinical outcome assessment (COA) and digital health technology development and optimization, including related study endpoint issues in R&D. Dr. Dashiell-Aje has also served in the Division of Clinical Outcome Assessments (DCOA) in the Office of New Drugs at FDA as a scientific lead and consultant to CDER, CBER, and CDRH and was a key player in shaping patient-focused drug development (PFDD) efforts. In addition, she has served as expert consultant to both pharmaceutical industry and federal government clients. As a health outcomes researcher and methodologist, Dr. Dashiell-Aje is driven by her passion for public health and promoting patient-focused medical product development. Dr. Dashiell-Aje has notably contributed her research expertise in academic, consulting, and regulatory environments to arrive at evidence-based solutions, and to shape health policy.